Insights from 2025 ASCO® GI Annual Meeting
Video Player is loading.
10 seconds
Playback speed
ASCO® GI 2025 Insights: Ph3 BREAKWATER Study - Encorafenib + Cetuximab + Chemo in 1L BRAF V600E-Mutant mCRC
By
Insights from 2025 ASCO® GI Annual Meeting
FEATURING
Scott Kopetz
By
Insights from 2025 ASCO® GI Annual Meeting
FEATURING
Scott Kopetz
Comments 0
Login to view comments.
Click here to Login
